Literature DB >> 222159

Arboviruses in New York State: an attempt to determine the role of arboviruses in patients with viral encephalitis and meningitis.

R Deibel, S Srihongse, J P Woodall.   

Abstract

In a reveiw of 2,963 patients with signs of infections of the central nervous system in New York State in 1966--1977, arboviruses were found to be the confirmed or presumptive etiologic agents in 60 patients. California encephalitis (CE) virus was the most common (44 patients), followed by Powassan (POW) virus (8), St. Louis encephalitis virus (7), and eastern equine encephalitis (EEE) virus (1). Most patients (47) were children. The incidence of encephalitis was higher in patients with arbovirus findings than in infections with any other of the common neurotropic viruses. The disease was fatal in two patients, one infected with POW virus, the other with EEE virus. Most patients with CE virus infections resided in suburban areas. All POW infections were contracted in six rural counties known for their recreational facilities.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222159

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

Review 1.  Powassan encephalitis: a case report with neuropathology and literature review.

Authors:  B I Gholam; S Puksa; J P Provias
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

2.  Balancing the risks: vector control and pesticide use in response to emerging illness.

Authors:  A Thier
Journal:  J Urban Health       Date:  2001-06       Impact factor: 3.671

3.  Powassan Virus Disease in the United States, 2006-2016.

Authors:  Elisabeth R Krow-Lucal; Nicole P Lindsey; Marc Fischer; Susan L Hills
Journal:  Vector Borne Zoonotic Dis       Date:  2018-03-13       Impact factor: 2.133

4.  Antibody and Viral Nucleic Acid Testing of Serum and Cerebrospinal Fluid for Diagnosis of Eastern Equine Encephalitis.

Authors:  James A Sherwood; David C Brittain; John J Howard; JoAnne Oliver
Journal:  J Clin Microbiol       Date:  2015-06-10       Impact factor: 5.948

Review 5.  Tick-Borne Flaviviruses, with a Focus on Powassan Virus.

Authors:  Gábor Kemenesi; Krisztián Bányai
Journal:  Clin Microbiol Rev       Date:  2018-12-12       Impact factor: 26.132

6.  Seroprevalence of Powassan Virus Infection in an Area Experiencing a Cluster of Disease Cases: Sussex County, New Jersey, 2019.

Authors:  Grace M Vahey; Nicolette Wilson; Emily McDonald; Kelly Fitzpatrick; Jennifer Lehman; Sandhya Clark; Kristine Lindell; Daniel M Pastula; Stephen Perez; Heather Rhodes; Carolyn V Gould; J Erin Staples; Kim Cervantes; Stacey W Martin
Journal:  Open Forum Infect Dis       Date:  2022-01-17       Impact factor: 3.835

Review 7.  Powassan Virus Encephalitis.

Authors:  Anne Piantadosi; Isaac H Solomon
Journal:  Infect Dis Clin North Am       Date:  2022-09       Impact factor: 5.905

8.  Aseptic meningitis epidemic during a West Nile virus avian epizootic.

Authors:  Kathleen G Julian; James A Mullins; Annette Olin; Heather Peters; W Allan Nix; M Steven Oberste; Judith C Lovchik; Amy Bergmann; Ross J Brechner; Robert A Myers; Anthony A Marfin; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

9.  Potential role of deer tick virus in Powassan encephalitis cases in Lyme disease-endemic areas of New York, U.S.A.

Authors:  Marc Y El Khoury; Jose F Camargo; Jennifer L White; Bryon P Backenson; Alan P Dupuis; Kay L Escuyer; Laura Kramer; Kirsten St George; Debarati Chatterjee; Melissa Prusinski; Gary P Wormser; Susan J Wong
Journal:  Emerg Infect Dis       Date:  2013-12       Impact factor: 6.883

10.  Cases of Eastern equine encephalitis in humans associated with Aedes canadensis, Coquillettidia perturbans and Culiseta melanura mosquitoes with the virus in New York State from 1971 to 2012 by analysis of aggregated published data.

Authors:  J A Sherwood; S V Stehman; J J Howard; J Oliver
Journal:  Epidemiol Infect       Date:  2020-04-01       Impact factor: 2.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.